"Charmaine died in her sleep on her 25th
birthday on New Year's Eve, 31/12/2009. Her
cause of death was Sudden Unexpected Death
in Epilepsy. Charmaine was actually having
tests under the hospital and had not yet found
the results of what she was suffering from,
though she was taking medication for epilepsy.
Charmaine started having fainting spells during her time at Preston University, while studying Criminal Law. She didn't start having seizures until three years later when she had returned home to Birmingham to her parents' house. She was placed on medication for epilepsy, as her mother has epilepsy.
Charmaine moved out of the family home
and settled into a flat where she began
a relationship with her boyfriend, Chris,
at the age of 22. She had just one bad seizure
during this period, and it was only during
her last few months that she started to
have fainting spells again. Charmaine started
having tests just before Christmas, and
it was a total shock to family and friends
when she passed away. Chaz, as she was also
known, leaves behind her mom Lisa, dad Carl,
brothers Martin and Ross and her only nephew
Rhys. She and her partner Chris were planning
to get married and start a family of their
own.
Charmaine worked for Virgin and lived her life to the full. She was a popular person and made a big impact on people. She will be greatly missed.
Charmaine's parents decided to collect donations from her friends for her funeral and have opened this memorial fund in her name to support Epilepsy Research UK. We hope you will help and support this worthy cause, not only to keep our daughter's memory alive, but to help others who struggle with epilepsy."
Lisa and Carl Heritage
February 2010
Donate to the
Charmaine Louise Heritage memorial
fund
Epilepsy Research UK would like to thank
Lisa and Carl Heritage for their involvement
with us. Our Memorial Funds play an essential
part in funding the charity's's research.
This year, they are supporting Professor
Matthew
Walker's project looking at Potassium
Channels in Epilepsy, which will increase
our understanding of the effect of epilepsy
on the brain, and may potentially open up
an exciting new avenue for epilepsy treatment.
